Literature DB >> 1831118

Postadolescent acne in women.

A M Kligman1.   

Abstract

A low-grade, persistent acne is quite common in hard-working professional women in their twenties, thirties, and forties. Closed comedones are the dominant lesions, with a scattering of papulopustules. Premenstrual flares are typical. Most such patients passed through adolescence without acne. Acne cosmetica has to be ruled out. The latter is more inflammatory and the lesions are denser. It is postulated that chronic stress leads to enhanced secretion of adrenal androgens, resulting in sebaceous hyperplasia and subsequent induction of comedones. Postadolescent acne is an authentic variety of acne vulgaris; it responds well to treatment with conventional topical medicaments.

Entities:  

Mesh:

Year:  1991        PMID: 1831118

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

Review 1.  [Clinical variants of acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 2.  Emerging Issues in Adult Female Acne.

Authors:  Joshua A Zeichner; Hillary E Baldwin; Fran E Cook-Bolden; Lawrence F Eichenfield; Sheila Fallon-Friedlander; David A Rodriguez
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

3.  A Prospective Study Examining Trigger Factors and Hormonal Abnormalities in Adult Female Acne.

Authors:  Prekshi Bansal; Kabir Sardana; Gauri Vats; Lokesh Sharma; Umesh Chandra Garga; Ananta Khurana
Journal:  Indian Dermatol Online J       Date:  2020-07-13

4.  The association between stress and acne among female medical students in Jeddah, Saudi Arabia.

Authors:  Shadi Zari; Dana Alrahmani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-05

5.  Keratosis pilaris and prevalence of acne vulgaris: a cross-sectional study.

Authors:  Juliano Vilaverde Schmitt; Brunno Zeni de Lima; Monique Carolina Meira do Rosário de Souza; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.